Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMedOpen access

Fibrin Scaffold With Concentrated Growth Factor and Stromal Vascular Fraction: A Novel Approach for Repairing Chronic Rotator Cuff Tears in a Rabbit Model.

Keskin A., Kabadayi Ensarioglu H., Vatansever HS., Gurbuz S., Guler Y., Karslioğlu B.

Laboratory Study on Tendon Injury, Rotator Cuff, published in Orthop J Sports Med (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Orthop J Sports Med (2025)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
41049598
PMCID
PMC12495194
DOI
10.1177/23259671251366686

Abstract (original English)

Rotator cuff tears (RCTs) represent a significant challenge in orthopaedic care, particularly in chronic cases where tendon healing is suboptimal. Novel biological therapies such as concentrated growth factor (CGF) and stromal vascular fraction (SVF) offer promising solutions for enhanced tendon repair. This study hypothesized that a fibrin scaffold enriched with CGF and SVF would improve tendon healing by reducing fatty degeneration, increasing vascularization, and enhancing biomechanical properties in a chronic RCT rabbit model. Controlled laboratory study. A chronic RCT model was developed in the subscapularis tendon of 28 male New Zealand rabbits. In the first phase (week 0), the chronic injury model was created surgically. At week 6, in addition to the transosseous repair technique, biological materials were applied into the bone tunnel in each group as follows: hydrogel (group 1), fibrin gel with CGF (group 2), CGF+SVF-enriched fibrin scaffold (group 3), and no repair (group 4). At week 12, animals were euthanized, and samples were collected for macroscopic, histological, immunohistochemical, and biomechanical analysis. Group 3 demonstrated a superior result. Fatty degeneration was significantly lower in group 3 compared with group 1 ( P = .045). Vascularization and cellularity scores were highest in group 3 (3.7 ± 0.5 and 3.6 ± 0.5, respectively), significantly greater t

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research